EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC | B761304 | ARGENX BV
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Jun. 20, 2035 | Active | Computed |
| 7-Year Orphan | Jun. 21, 1931 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12403175(method of use) · relevance 95/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
45 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.